Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: A prospective study

The present study is aimed to evaluate the effect of the herbal drug Salacia oblonga on reduction of cardiovascular risk factors in patients with chronic kidney disease (CKD). Sixty patients were randomized in four groups; group A1 = non-diabetic CKD given trial drug Salacia oblonga for six months,...

Full description

Bibliographic Details
Main Authors: Rana Gopal Singh, Surendra Singh Rathore, Imtiyaz Ahmad Wani, Usha, Aruna Agrawal, Govind Prasad Dubey
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2015;volume=26;issue=1;spage=61;epage=66;aulast=Singh
id doaj-3a478ee2f9c24281ba480041c4852917
record_format Article
spelling doaj-3a478ee2f9c24281ba480041c48529172020-11-25T01:04:31ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422015-01-01261616610.4103/1319-2442.148736Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: A prospective studyRana Gopal SinghSurendra Singh RathoreImtiyaz Ahmad WaniUshaAruna AgrawalGovind Prasad DubeyThe present study is aimed to evaluate the effect of the herbal drug Salacia oblonga on reduction of cardiovascular risk factors in patients with chronic kidney disease (CKD). Sixty patients were randomized in four groups; group A1 = non-diabetic CKD given trial drug Salacia oblonga for six months, group A 2 = non-diabetic CKD intended to receive placebo, group B1 = diabetic CKD treated with Salacia oblonga for six months and group B 2 = diabetic CKD patients intended to receive placebo. Estimation of renal function tests including blood urea, serum creatinine and creatinine clearance was performed at baseline and after that at monthly intervals. Lipid profile, interleukin-6 (IL-6) and C-reactive protein (CRP) were measured at baseline and were repeated at three months and six months. After six months of treatment, Salacia oblonga could reduce the triglyceride levels by 23.66% (P = 0.008) in non-diabetic and by 17.45% (P = 0.01) in diabetic CKD patients. In comparison with placebo, both non-diabetic and diabetic CKD patients treated with Salacia oblonga showed significant reduction in CRP levels (P = 0.002 and 0.03, respectively), while significant reduction in IL-6 (P-value = 0.0003) and serum cholesterol levels (P-value = 0.0001) was seen only in diabetic CKD patients treated with Salacia oblonga. Stabilization of creatinine clearance with Salacia oblonga was observed in both non-diabetic (P = 0.05) and diabetic CKD (P = 0.04) patients in comparison with placebo. Salacia oblonga has significant beneficial effects on lipid profile and markers of inflammation and endothelial dysfunction in CKD patients. Salacia oblonga also seems to have a reno-protective effect, as reflected by stabilization of creatinine clearance at six months in this study.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2015;volume=26;issue=1;spage=61;epage=66;aulast=Singh
collection DOAJ
language English
format Article
sources DOAJ
author Rana Gopal Singh
Surendra Singh Rathore
Imtiyaz Ahmad Wani
Usha
Aruna Agrawal
Govind Prasad Dubey
spellingShingle Rana Gopal Singh
Surendra Singh Rathore
Imtiyaz Ahmad Wani
Usha
Aruna Agrawal
Govind Prasad Dubey
Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: A prospective study
Saudi Journal of Kidney Diseases and Transplantation
author_facet Rana Gopal Singh
Surendra Singh Rathore
Imtiyaz Ahmad Wani
Usha
Aruna Agrawal
Govind Prasad Dubey
author_sort Rana Gopal Singh
title Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: A prospective study
title_short Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: A prospective study
title_full Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: A prospective study
title_fullStr Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: A prospective study
title_full_unstemmed Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: A prospective study
title_sort effects of salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: a prospective study
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Kidney Diseases and Transplantation
issn 1319-2442
publishDate 2015-01-01
description The present study is aimed to evaluate the effect of the herbal drug Salacia oblonga on reduction of cardiovascular risk factors in patients with chronic kidney disease (CKD). Sixty patients were randomized in four groups; group A1 = non-diabetic CKD given trial drug Salacia oblonga for six months, group A 2 = non-diabetic CKD intended to receive placebo, group B1 = diabetic CKD treated with Salacia oblonga for six months and group B 2 = diabetic CKD patients intended to receive placebo. Estimation of renal function tests including blood urea, serum creatinine and creatinine clearance was performed at baseline and after that at monthly intervals. Lipid profile, interleukin-6 (IL-6) and C-reactive protein (CRP) were measured at baseline and were repeated at three months and six months. After six months of treatment, Salacia oblonga could reduce the triglyceride levels by 23.66% (P = 0.008) in non-diabetic and by 17.45% (P = 0.01) in diabetic CKD patients. In comparison with placebo, both non-diabetic and diabetic CKD patients treated with Salacia oblonga showed significant reduction in CRP levels (P = 0.002 and 0.03, respectively), while significant reduction in IL-6 (P-value = 0.0003) and serum cholesterol levels (P-value = 0.0001) was seen only in diabetic CKD patients treated with Salacia oblonga. Stabilization of creatinine clearance with Salacia oblonga was observed in both non-diabetic (P = 0.05) and diabetic CKD (P = 0.04) patients in comparison with placebo. Salacia oblonga has significant beneficial effects on lipid profile and markers of inflammation and endothelial dysfunction in CKD patients. Salacia oblonga also seems to have a reno-protective effect, as reflected by stabilization of creatinine clearance at six months in this study.
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2015;volume=26;issue=1;spage=61;epage=66;aulast=Singh
work_keys_str_mv AT ranagopalsingh effectsofsalaciaoblongaoncardiovascularriskfactorsinchronickidneydiseasepatientsaprospectivestudy
AT surendrasinghrathore effectsofsalaciaoblongaoncardiovascularriskfactorsinchronickidneydiseasepatientsaprospectivestudy
AT imtiyazahmadwani effectsofsalaciaoblongaoncardiovascularriskfactorsinchronickidneydiseasepatientsaprospectivestudy
AT usha effectsofsalaciaoblongaoncardiovascularriskfactorsinchronickidneydiseasepatientsaprospectivestudy
AT arunaagrawal effectsofsalaciaoblongaoncardiovascularriskfactorsinchronickidneydiseasepatientsaprospectivestudy
AT govindprasaddubey effectsofsalaciaoblongaoncardiovascularriskfactorsinchronickidneydiseasepatientsaprospectivestudy
_version_ 1725197473322893312